Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Hematology
- Depression
- Nutrition and Dietetics
- Orthopedics & Rheumatology
- Gerontology
- Anesthesiology and Pain Medicine
- Pharmacology and Therapeutics
- Gastroenterology
Abstract
Citation: Clin Case Rep Int. 2017;1(1):1023.DOI: 10.25107/2638-4558.1023
Leptomeningeal Metastasis in Non-Small Cell Lung Cancer: A Report of Two Cases and Short Rewiev of Literature
Pinar Akın Kabalak, Derya Kizilgoz, Tuba Inal Cengiz, Ulku Yilmaz, Sebnem Yucel and Suzan Biri
Department of Chest Disease, Ankara Atatürk Chest Disease and Thoracic Surgery Training and Research Hospital, Turkey Department of Medical Oncology, Ankara Atatürk Chest Disease and Thoracic Surgery Training and Research Hospital, Turkey Department of Radiology, Ankara Atatürk Chest Disease and Thoracic Surgery Training and Research Hospital, Turkey
*Correspondance to: Pinar Akin Kabalak
PDF Full Text Case Report | Open Access
Abstract:
Central Nervous System (CNS) metastasis cause serious clinical deterioration in patient with NonSmall Cell Lung Cancer (NSCLC). Systemic cytotoxic agents, Whole Brain Irradiation (WBRT), oral targeted therapies and Intrathecal Chemotherapy (IC) are well known treatment options. In first case we aim to share two lung cancer patients at young ages with Leptomeningeal Metastasis (LM) treated with oral targeted therapies combined with WBRT.
Keywords:
Non-small cell lung cancer; Leptomeningeal metastasis; Neuroimaging; Epidermal growth factor receptor tyrosine kinase inhibitors; ALK inhibitor
Cite the Article:
Kabalak PA, Kızılgöz D, Cengiz Tİ, Yılmaz Ü, Yücel Ş, Biri S. Leptomeningeal Metastasis in NonSmall Cell Lung Cancer: A Report of Two Cases and Short Rewiev of Literature. Clin Case Rep Int. 2017; 1: 1023.